Imago Biosciences has announced plans to file for an IPO in the US, while The Trendlines Group Ltd has retracted its IPO application on the Tel Aviv Stock Exchange in Israel.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
